Popular stocks:

GameStop

Zomedica

Churchill Capital Corp IV

All currency forecasts

All stock predictions

All cryptocurrency predictions

All stock index forecasts

G1 Therapeutics (GTHX) stock forecast for 2023

The forecast has been updated: March 19, 2023 12:23

G1 Therapeutics stock price online today

Analyst Target Price

13.83

Dividend Date

Ex Dividend Date

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell G1 Therapeutics stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? G1 Therapeutics stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $13.83 target price for G1 Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (8.14 $).

50 Day Moving Average is the resistance level (5.18 $).

GTHX Forecast for 2023

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Apr	2.78	2.39	3.29	27.37 %
May	3.23	2.99	3.44	13.19 %
Jun	2.99	2.44	3.53	30.87 %
Jul	2.77	2.30	3.14	26.71 %
Aug	2.67	2.49	3.05	18.19 %
Sep	2.36	2.19	2.65	17.57 %
Oct	2.54	2.36	3.06	22.68 %
Nov	2.53	2.26	2.67	15.37 %
Dec	2.79	2.34	3.20	27.04 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of G1 Therapeutics stock.

G1 Therapeutics overview

G1 Therapeutics Address

79 T.W. ALEXANDER DRIVE, 4501 RESEARCH COMMONS, SUITE 100, RESEARCH TRIANGLE PARK, NC, US

Market Capitalization

155 489 000 $

EBITDA

-135 648 000

PE Ratio

None

PEG Ratio

Dividend Per Share

Dividend Yield

EPS

-3.21

Quarterly Earnings Growth YOY

Quarterly Revenue Growth YOY

0.768

Trailing PE

Forward PE

EV To Revenue

6.04

EV To EBITDA

-1.986

52 Week High

17.49

52 Week Low

2.95

50 Day Moving Average

5.18

200 Day Moving Average

8.14

Shares Outstanding

51658000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

G1 Therapeutics stock forecast for this year

G1 Therapeutics stock forecast for Apr 2023.
Estimated Average Forecasted G1 Therapeutics Price: 2.78. Positive monthly dynamics of the instrument is expected with 27.374% volatility is expected.

Pessimistic forecast: 2.39

Optimistic: 3.29

G1 Therapeutics stock forecast for May 2023.
Estimated Average Forecasted G1 Therapeutics Price: 3.23. Positive monthly dynamics of the instrument is expected with 13.186% volatility is expected.

Pessimistic forecast: 2.99

Optimistic: 3.44

G1 Therapeutics stock forecast for Jun 2023.
Estimated Average Forecasted G1 Therapeutics Price: 2.99. Negative monthly dynamics of the instrument is expected with 30.866% volatility is expected.

Pessimistic forecast: 2.44

Optimistic: 3.53

G1 Therapeutics stock forecast for Jul 2023.
Estimated Average Forecasted G1 Therapeutics Price: 2.77. Negative monthly dynamics of the instrument is expected with 26.707% volatility is expected.

Pessimistic forecast: 2.30

Optimistic: 3.14

G1 Therapeutics stock forecast for Aug 2023.
Estimated Average Forecasted G1 Therapeutics Price: 2.67. Negative monthly dynamics of the instrument is expected with 18.188% volatility is expected.

Pessimistic forecast: 2.49

Optimistic: 3.05

G1 Therapeutics stock forecast for Sep 2023.
Estimated Average Forecasted G1 Therapeutics Price: 2.36. Negative monthly dynamics of the instrument is expected with 17.575% volatility is expected.

Pessimistic forecast: 2.19

Optimistic: 2.65

G1 Therapeutics stock forecast for Oct 2023.
Estimated Average Forecasted G1 Therapeutics Price: 2.54. Positive monthly dynamics of the instrument is expected with 22.678% volatility is expected.

Pessimistic forecast: 2.36

Optimistic: 3.06

G1 Therapeutics stock forecast for Nov 2023.
Estimated Average Forecasted G1 Therapeutics Price: 2.53. Negative monthly dynamics of the instrument is expected with 15.370% volatility is expected.

Pessimistic forecast: 2.26

Optimistic: 2.67

G1 Therapeutics stock forecast for Dec 2023.
Estimated Average Forecasted G1 Therapeutics Price: 2.79. Positive monthly dynamics of the instrument is expected with 27.035% volatility is expected.

Pessimistic forecast: 2.34

Optimistic: 3.20

All currency forecasts

All stock predictions

All cryptocurrency predictions

All stock index forecasts

Other Healthcare sector assets

Name	Symbol	Last Close Price	Change
Abbott Laboratories	ABT	97.87 (20.03.2023)	0.89 %
AbbVie Inc.	ABBV	156.12 (20.03.2023)	1.23 %
Aeterna Zentaris Inc.	AEZS	2.63 (20.03.2023)	-3.13 %
Allakos Inc.	ALLK	4.96 (20.03.2023)	-8.99 %
Allogene Therapeutics, Inc.	ALLO	5.37 (20.03.2023)	-2.19 %
Amgen Inc.	AMGN	234.72 (20.03.2023)	2.15 %
Aphria Inc.	APHA	15.38 (07.05.2021)	0.00 %
Atara Biotherapeutics, Inc.	ATRA	2.98 (20.03.2023)	-1.32 %
Aurora Cannabis Inc.	ACB	0.6642 (20.03.2023)	-9.01 %
Becton Dickinson and Company	BDX	238.49 (20.03.2023)	1.24 %
Biogen Inc.	BIIB	266.15 (21.03.2023)	-0.66 %
Biohaven Pharmaceutical Holding Company Ltd.	BHVN	13.94 (20.03.2023)	1.23 %
BioNTech SE	BNTX	132.08 (20.03.2023)	1.88 %
bluebird bio, Inc.	BLUE	4.47 (20.03.2023)	-1.54 %
Boston Scientific Corp.	BSX	48.83 (20.03.2023)	1.84 %
Bristol-Myers Squibb Company	BMY	67.51 (21.03.2023)	0.40 %
Canopy Growth Corp.	CGC	1.86 (20.03.2023)	-7.00 %
Castle Biosciences, Inc.	CSTL	21.33 (20.03.2023)	-0.33 %
CLOVER HEALTH INVESTMENTS, CORP	CLOV	3.16 (07.01.2022)	-5.67 %
Eli Lilly and Company	LLY	242.27 (04.02.2022)	0.00 %
Emergent BioSolutions Inc.	EBS	8.07 (20.03.2023)	-0.62 %
Exelixis, Inc.	EXEL	18.56 (17.06.2022)	5.63 %
G1 Therapeutics, Inc.	GTHX	2.94 (20.03.2023)	-2.33 %
Gilead Sciences, Inc.	GILD	79.46 (20.03.2023)	2.78 %
GlaxoSmithKline plc	GSK	34.93 (20.03.2023)	2.52 %
GoodRx Holdings, Inc.	GDRX	6.45 (20.03.2023)	-1.38 %
GW Pharmaceuticals plc.	GWPH	218.96 (05.05.2021)	0.00 %
Incyte Corp.	INCY	73.49 (21.03.2023)	-0.98 %
Inovio Pharmaceuticals, Inc.	INO	1.04 (21.03.2023)	-2.80 %
Johnson & Johnson	JNJ	153.89 (21.03.2023)	0.00 %
Medtronic plc.	MDT	79.61 (20.03.2023)	1.69 %
Merck & Co., Inc.	MRK	105.54 (21.03.2023)	-0.29 %
Moderna, Inc.	MRNA	154.52 (20.03.2023)	3.00 %
Novartis AG	NVS	83.43 (20.03.2023)	1.51 %
Novavax, Inc.	NVAX	5.98 (20.03.2023)	0.50 %
ObsEva SA	OBSV	0.1185 (20.03.2023)	-4.36 %
OrganiGram Holdings Inc.	OGI	0.653 (21.03.2023)	9.23 %
Pfizer Inc.	PFE	40.81 (20.03.2023)	1.77 %
Regeneron Pharmaceuticals, Inc.	REGN	759.76 (21.03.2023)	0.07 %
Sanofi	SNY	48 (20.03.2023)	0.54 %
Schrodinger, Inc.	SDGR	25.39 (20.03.2023)	-0.90 %
Senseonics Holdings, Inc.	SENS	0.8408 (20.03.2023)	1.96 %
Sorrento Therapeutics, Inc.	SRNE	0.3701 (20.03.2023)	4.84 %
Stryker Corp.	SYK	276.83 (20.03.2023)	0.87 %
Sundial Growers Inc.	SNDL	1.58 (21.03.2023)	8.22 %
Teva Pharmaceutical Industries Lim. (TEVA)	TEVA	8.53 (20.03.2023)	2.03 %
Thermo Fisher Scientific Inc.	TMO	550.57 (20.03.2023)	0.59 %
Tilray, Inc.	TLRY	2.66 (21.03.2023)	7.26 %
UnitedHealth Group, Inc.	UNH	476.96 (20.03.2023)	1.59 %
Veeva Systems Inc.	VEEV	177.08 (21.03.2023)	2.04 %
Zomedica Corp.	ZOM	0.2031 (20.03.2023)	6.89 %
Zynerba Pharmaceuticals, Inc.	ZYNE	0.4511 (20.03.2023)	2.52 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.